The tonometer is a tool used to measure pressure in various body parts, including the eyeball or intraocular pressure, which refers to the pressure of the fluid inside the eye. The main purpose of tonometry as a diagnostic procedure is to look for glaucoma. Finding out whether a patient is at risk for glaucoma is another crucial aspect of the test. The majority of tonometers have been calibrated to measure pressure in millimetres of mercury (mm of Hg).
Global tonometry device market is estimated to be valued at US$ 109.68 million in 2022 and is expected to exhibit a CAGR of 6.1% during the forecast period (2022-2030).
Figure 1. Global Tonometry Device Market Share (%), by Application, 2022
Global Tonometry Device Market- Drivers
Arterial blood pressure is used for the assessment of cardiac function. The measurement of the systolic and diastolic blood pressure on the brachial artery is used for the diagnosis and management of hypertension. However, for the assessment of central aortic blood pressure, aortic and carotid pressures that can be measured by tonometry are physiologically more relevant and superior to peripheral brachial pressure. Central aortic blood pressure (CBP) is considered a better cardiovascular prognostic marker than conventional cuff brachial blood pressure. Therefore, the rising prevalence of cardiovascular devices is expected to increase the demand for devices that can efficiently detect the risk of cardiovascular diseases at an early stage to avoid serious complications. For instance, according to the data provided by the Centers for Disease Control and Prevention, in July 2022, heart disease is the leading cause of death for women, men, and people of most racial and ethnic groups in the U.S. Moreover, according to the same source, one person dies every 34 seconds in the U.S. from cardiovascular disease. In the year 2020, about 697,000 people died from heart disease in the U.S. that is 1 in every 5 deaths.
Blood pressure monitoring is a vital part of care for patients admitted to the Intensive Care Units (ICUs). The most commonly used procedures for blood pressure (BP) monitoring involve either non-invasive inflatable cuff-based oscillometric or invasive arterial line manometric measurement. However, inflatable BP cuffs take intermittent measurements that are typically limited in frequency to no more than one measurement every 5 min due to patient discomfort and the risk of skin and nerve damage. Tonometry is a noninvasive and reproducible method that can detect aortic and carotid pressures. Tonometry can overcome the shortcomings of inflatable cuff-based blood pressure monitoring devices. Tonometry monitoring devices have certain advantages over such devices, which is expected to drive the market growth over the forecast period. For instance, arterial applanation tonometry allows for monitoring the blood pressure waveform, overcoming the limitation of the inflatable cuff method that can only measure discrete value of systolic and diastolic blood pressure.
|Base Year:||2021||Market Size in 2022:||US$ 109.68 Mn|
|Historical Data for:||2017 to 2020||Forecast Period:||2022 to 2030|
|Forecast Period 2022 to 2030 CAGR:||6.1%||2030 Value Projection:||US$ 176.02 Mn|
ATCOR, Millar, OMRON HEALTHCARE Co.,Ltd., DAEYOMEDI, MedTach, Itamar Medical Ltd., DiaTecne s.r.l., Alam Medical, Cardiovascular Engineering Inc., OCULUS, Keeler, Haag-Streit Group, SunTechMedical, Inc., Osypka Medical and Shenzhen Mindray Bio-Medical Electronics Co Ltd.
|Restraints & Challenges:||
Figure 2. Global Tonometry Device Market Share (%), by Region, 2022
Global Tonometry Device Market– Impact of Coronavirus (COVID-19) Pandemic
Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization had declared it a public health emergency on January 30, 2020.
Three main ways in which COVID-19 has impacted the economy are through direct impact on medication and vaccine demand and manufacturing, interruptions in the distribution system, and financial impact on businesses and financial markets. Several nations, including China, India, Saudi Arabia, the United Arab Emirates, Egypt, and others, experienced issues with the transit of medicines and vaccinations from one location to another as a result of nationwide lockdowns.
Supply chain and manufacturing activities have been disrupted globally, due to lockdowns implemented by governments, restricted movement, and other COVID-19 safety precautions. Similarly, the supply chain for tonometry device was disrupted during the pandemic.
Moreover, COVID-19 pandemic is expected to have a negative effect on the overall global tonometry device market due to significant decrease in the number of cardiac devices implantation. According to an article published by the Journal of the American College of Cardiology in November 2020, the COVID-19 pandemic has adversely affected patient care and the conduct of clinical trials in all fields of healthcare, including cardiology. The same source estimates that in April 2020, around 90% of clinical trial sites were closed to enrollment worldwide, with a 95% decline in cardiovascular trial activity.
Global Tonometry Device Market: Key Developments
In April 2020, AliveCor, a medical device company, and OMRON Healthcare, Co., Ltd., a medical equipment manufacturing company, announced a global, partnership in which AliveCor's ECG technology and blood pressure devices from OMRON is combined together to expand access in remote patient care. This partnership aligns with global trends to deploy non-invasive remote monitoring devices to facilitate patient monitoring while reducing patient and healthcare provider contact during the current pandemic i.e. COVID-19.
In September 2021, ZOLL Medical Corporation, an Asahi Kasei company, signed a definitive agreement with Itamar Medical Ltd., a medical device and digital health company focused on the integration of sleep apnea diagnosis into the cardiac patient care pathway, announced that ZOLL Medical will acquire all ordinary shares of Itamar for a total value of around US$ 538 million.
Global Tonometry Device Market: Restraint
The major factors that hinder growth of the global tonometry device market include the presence of other substitutes for pressure monitoring in the market is expected to act as a restraint for the market growth.
Various pressure monitoring devices in the market include manual blood pressure monitors and digital blood pressure monitors. Manual devices include a cuff that is wrapped around the arm, a rubber squeeze bulb, and a gauge that measures the blood pressure. Digital devices also have a cuff that is wrapped around the arm and to inflate the cuff, a rubber squeeze ball is employed. Other kinds will inflate automatically when a button is pushed.
Global Tonometry Device Market- Key Players
Major players operating in the global tonometry device market include ATCOR, Millar, OMRON HEALTHCARE Co.,Ltd., DAEYOMEDI, MedTach, Itamar Medical Ltd., DiaTecne s.r.l., Alam Medical, Cardiovascular Engineering Inc., OCULUS, Keeler, Haag-Streit Group, SunTechMedical, Inc., Osypka Medical and Shenzhen Mindray Bio-Medical Electronics Co Ltd.
Tonometry means "to measure pressure" while applanation means "to flatten out." Radial artery (AT) is performed by placing a handheld tonometer (strain gauge pressure sensor) over the radial artery and applying gentle pressure to partially flatten the artery. Tonometers are instruments that let ophthalmologists measure the intraocular pressure (IOP) inside the eye. IOP stands for intraocular pressure. A diagnostic procedure called tonometry can help determine a patient's glaucoma risk. With this eye condition, there is too much fluid pressure inside the eye, which can harm the patient's optic nerve and, if left untreated, cause permanent vision loss. Tonometers are useful for spotting this condition, which typically does not manifest symptoms until much later. The older population is a prominent target for this type of sickness. Furthermore, people with diabetes have an increased chance of developing glaucoma. Tonometers are therefore increasingly beneficial for this target population.
Major companies operating in the global tonometry device market are focused on organic growth strategies such as product launch and approvals, which is expected to drive growth of the global tonometry device market over the forecast period. For instance, in August 2022, in August, Millar, Inc., a medical equipment manufacturing company announced that it had received approval from the Therapeutic Goods Administration (TGA) in Australia for its Mikro-Cath Pressure Catheter. The Mikro-Cath is a single use pressure catheter used for medical research and diagnostic purposes. The catheter is indicated to measure cardiovascular, intra-compartmental, and airway pressures in the human body under short-term limited body contact (<24 hours). Moreover, For instance, in October 2021, CardieX, a global health technology company, had announced the launch of a wearable device, a smartwatch, developed by CardieX subsidiary ATCOR, a medical device company, using SphygmoCor technology and Mobvoi, an electronics company using Arty Heart Health analytics platform.
Key features of the study:
“*” marked represents similar segmentation in other categories in the respective section.